Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

Official URL:https://doi.org/10.1016/j.tins.2006.07.006
PubMed:View item in PubMed
Creators Name:Zipp, F. and Aktas, O.
Journal Title:Trends in Neurosciences
Journal Abbreviation:Trends Neurosci
Volume:29
Number:9
Page Range:518-527
Date:September 2006
Keywords:Immunotherapy, Inflammation, Multiple Sclerosis, Nerve Degeneration, Neurodegenerative Diseases, Animals
Abstract:Classical knowledge distinguishes between inflammatory and non-inflammatory diseases of the brain. Either the immune system acts on the CNS and initiates a damage cascade, as in autoimmune (e.g. multiple sclerosis) and infectious conditions, or the primary insult is not inflammation but ischemia or degeneration, as in stroke and Alzheimer's disease, respectively. However, as we review here, recent advances have blurred this distinction. On the one hand, the classical inflammatory diseases of the brain also exhibit profound and early neurodegenerative features - remarkably, it has been known for more than a century that neuronal damage is a key feature of multiple sclerosis pathology, yet this was neglected until very recently. On the other hand, immune mechanisms might set the pace of progressive CNS damage in primary neurodegeneration. Despite differing initial events, increasing evidence indicates that even in clinically heterogeneous diseases, there might be common immunological pathways that result in neurotoxicity and reveal targets for more efficient therapies.
ISSN:0166-2236
Publisher:Elsevier (The Netherlands)
Additional Information:The original publication is available at www.sciencedirect.com
Item Type:Review

Repository Staff Only: item control page

Open Access
MDC Library